Remove Dosage Remove FDA Remove Webinar
article thumbnail

The key role of GMP analytical testing for drug products

European Pharmaceutical Review

One of the most significant challenges is keeping up with the changing regulatory requirements set by agencies such as the US FDA, EMA and International Council for Harmonisation (ICH). For solid dosage forms, including capsules, tablets, or film-coated tablets, dissolution tests are conducted. Any identified gaps have been addressed.

Dosage 52
article thumbnail

Conversion Rate Optimization for Pharma: Boosting HCP & Patient Engagement

Pharma Marketing Network

Whether thats requesting medical samples, signing up for a webinar, or downloading patient education materials , CRO helps ensure visitors dont just browsethey take action. Offer interactive tools like symptom checkers and dosage calculators. But patients often abandon pages if content is confusing or lacks trust signals.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

For instance, the FDA’s requirement for Patient Perspectives in drug reviews has made patient engagement crucial for approvals and reimbursements. This education can be delivered through various formats, such as webinars, videos, and written materials.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

A recent draft from the FDA provides valuable insight. In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs. What will the future hold for clinical research?